Literature DB >> 1864965

Lipolysis exposes unreactive endogenous apolipoprotein E-3 in human and rat plasma very low density lipoprotein.

E Sehayek1, U Lewin-Velvert, T Chajek-Shaul, S Eisenberg.   

Abstract

Endogenous apolipoprotein E in VLDL is poorly expressed in receptor binding processes. Yet catabolism of VLDL-remnants by cellular receptors depends on functional apo E molecules. To better understand remnant catabolism phenomena, we determined the metabolism of VLDL and post-lipolysis VLDL by cultured cells. Partial lipolysis was achieved by incubation of VLDL with lipoprotein lipase in vitro (human) or recirculation (rat) in supradiaphragmatic animals. Lipolyzed VLDL exhibit metabolic activities 2-20-fold higher than control VLDL, that are saturable and dependent on the presence of LDL receptors. The ligand responsible for receptor interaction of lipolyzed VLDL (apo E or apo B-100) and its source (endogenous or transferred) was studied with monoclonal antibodies and with lipoproteins from E-3/3 and E-2/2 subjects. The data unequivocally proved that lipolysis causes exposure of unreactive endogenous apo E-3 at the VLDL surface, possibly by a change of conformation of the protein. Apo B-100 becomes biologically expressed only in lipolyzed VLDL-III. Lipolyzed VLDL, however, is less reactive to exogenous apo E-3 than control VLDL indicating that endogenous and exogenous apo E are oriented differently in VLDL. It is proposed that VLDL delivers triglycerides to tissues when apo E is unreactive but becomes a remnant after the protein becomes exposed and directs the particles from lipoprotein lipase sites to cellular receptors.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1864965      PMCID: PMC295385          DOI: 10.1172/JCI115339

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  31 in total

1.  Increased clearance of plasma cholesterol after injection of apolipoprotein E into Watanabe heritable hyperlipidemic rabbits.

Authors:  N Yamada; H Shimano; H Mokuno; S Ishibashi; T Gotohda; M Kawakami; Y Watanabe; Y Akanuma; T Murase; F Takaku
Journal:  Proc Natl Acad Sci U S A       Date:  1989-01       Impact factor: 11.205

2.  The reliability of molecular weight determinations by dodecyl sulfate-polyacrylamide gel electrophoresis.

Authors:  K Weber; M Osborn
Journal:  J Biol Chem       Date:  1969-08-25       Impact factor: 5.157

Review 3.  George Lyman Duff memorial lecture. Role of the liver in atherosclerosis.

Authors:  R J Havel
Journal:  Arteriosclerosis       Date:  1985 Nov-Dec

4.  Enhanced metabolism of normolipidemic human plasma very low density lipoprotein in cultured cells by exogenous apolipoprotein E-3.

Authors:  S Eisenberg; G Friedman; T Vogel
Journal:  Arteriosclerosis       Date:  1988 Sep-Oct

5.  Intravenous infusion of apolipoprotein E accelerates clearance of plasma lipoproteins in rabbits.

Authors:  R W Mahley; K H Weisgraber; M M Hussain; B Greenman; M Fisher; T Vogel; M Gorecki
Journal:  J Clin Invest       Date:  1989-06       Impact factor: 14.808

Review 6.  Mechanisms of primary hypercholesterolemia in humans.

Authors:  G L Vega; S M Grundy
Journal:  Am Heart J       Date:  1987-02       Impact factor: 4.749

7.  Apolipoprotein E is the determinant that mediates the receptor uptake of beta-very low density lipoproteins by mouse macrophages.

Authors:  T L Innerarity; K S Arnold; K H Weisgraber; R W Mahley
Journal:  Arteriosclerosis       Date:  1986 Jan-Feb

8.  Low density lipoprotein receptor-related protein mediates uptake of cholesteryl esters derived from apoprotein E-enriched lipoproteins.

Authors:  R C Kowal; J Herz; J L Goldstein; V Esser; M S Brown
Journal:  Proc Natl Acad Sci U S A       Date:  1989-08       Impact factor: 11.205

9.  Inhibitory effects of C apolipoproteins from rats and humans on the uptake of triglyceride-rich lipoproteins and their remnants by the perfused rat liver.

Authors:  E Windler; R J Havel
Journal:  J Lipid Res       Date:  1985-05       Impact factor: 5.922

10.  Surface location and high affinity for calcium of a 500-kd liver membrane protein closely related to the LDL-receptor suggest a physiological role as lipoprotein receptor.

Authors:  J Herz; U Hamann; S Rogne; O Myklebost; H Gausepohl; K K Stanley
Journal:  EMBO J       Date:  1988-12-20       Impact factor: 11.598

View more
  7 in total

1.  Suppression of diet-induced atherosclerosis in low density lipoprotein receptor knockout mice overexpressing lipoprotein lipase.

Authors:  M Shimada; S Ishibashi; T Inaba; H Yagyu; K Harada; J I Osuga; K Ohashi; Y Yazaki; N Yamada
Journal:  Proc Natl Acad Sci U S A       Date:  1996-07-09       Impact factor: 11.205

Review 2.  How do elevated triglycerides and low HDL-cholesterol affect inflammation and atherothrombosis?

Authors:  Francine K Welty
Journal:  Curr Cardiol Rep       Date:  2013-09       Impact factor: 2.931

Review 3.  Hypobetalipoproteinemia and abetalipoproteinemia.

Authors:  Francine K Welty
Journal:  Curr Opin Lipidol       Date:  2014-06       Impact factor: 4.776

4.  Lipoprotein lipase- and hepatic triglyceride lipase- promoted very low density lipoprotein degradation proceeds via an apolipoprotein E-dependent mechanism.

Authors:  J D Medh; G L Fry; S L Bowen; S Ruben; H Wong; D A Chappell
Journal:  J Lipid Res       Date:  2000-11       Impact factor: 5.922

Review 5.  Targeting inflammation in metabolic syndrome.

Authors:  Francine K Welty; Abdulhamied Alfaddagh; Tarec K Elajami
Journal:  Transl Res       Date:  2015-07-03       Impact factor: 7.012

6.  Mechanism of hypertriglyceridemia in human apolipoprotein (apo) CIII transgenic mice. Diminished very low density lipoprotein fractional catabolic rate associated with increased apo CIII and reduced apo E on the particles.

Authors:  K Aalto-Setälä; E A Fisher; X Chen; T Chajek-Shaul; T Hayek; R Zechner; A Walsh; R Ramakrishnan; H N Ginsberg; J L Breslow
Journal:  J Clin Invest       Date:  1992-11       Impact factor: 14.808

7.  Lipoprotein lipase enhances binding of lipoproteins to heparan sulfate on cell surfaces and extracellular matrix.

Authors:  S Eisenberg; E Sehayek; T Olivecrona; I Vlodavsky
Journal:  J Clin Invest       Date:  1992-11       Impact factor: 14.808

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.